EUVIMEDEUVIMED entdecken
Crossref

Investigation of circulating miR-182-3p, miR -382-3p and miR -93, miR -142-3p involved in tamoxifen resistance and sensitivity in luminal-subtype breast cancer patients: a case–control study

Elmira Aboutalebi Vand Beilankouhi, Zohreh Sanaat, Mohammad Ali Hosseinpour Feizi, Amir Mehdizadeh, Reza Safaralizadeh

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025-06 · 398 (6) · 7505-7516

DOI: 10.1007/s00210-024-03770-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 04.01.2025. Verfasst von Elmira Aboutalebi Vand Beilankouhi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms, Tamoxifen, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsBreast NeoplasmsTamoxifenDrug Resistance, NeoplasmAntineoplastic Agents, HormonalHumansFemaleMiddle AgedCase-Control StudiesAdultAgedBiomarkers, Tumor

Stichwörter der Autor:innen

BiomarkerBreast cancerMiRNATamoxifen

Substanzen

MicroRNAsTamoxifenMIRN93 microRNA, humanAntineoplastic Agents, HormonalMirn182 microRNA, humanMIRN142 microRNA, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.
  • Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. mehdizadeha@tbzmed.ac.ir.
  • Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran. safaralizadeh@tabrizu.ac.ir.

Zitieren

APA

Aboutalebi Vand Beilankouhi, E., Sanaat, Z., Hosseinpour Feizi, M. A., Mehdizadeh, A., & Safaralizadeh, R. (2025). Investigation of circulating miR-182-3p, miR -382-3p and miR -93, miR -142-3p involved in tamoxifen resistance and sensitivity in luminal-subtype breast cancer patients: a case–control study. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(6), 7505-7516. https://doi.org/10.1007/s00210-024-03770-9

Vancouver

Aboutalebi Vand Beilankouhi E, Sanaat Z, Hosseinpour Feizi MA, Mehdizadeh A, Safaralizadeh R. Investigation of circulating miR-182-3p, miR -382-3p and miR -93, miR -142-3p involved in tamoxifen resistance and sensitivity in luminal-subtype breast cancer patients: a case–control study. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025;398(6):7505-7516. doi:10.1007/s00210-024-03770-9

BibTeX
@article{AboutalebiVandBeilankouhi2025,
  author = {Aboutalebi Vand Beilankouhi, Elmira and Sanaat, Zohreh and Hosseinpour Feizi, Mohammad Ali and Mehdizadeh, Amir and Safaralizadeh, Reza},
  title = {Investigation of circulating miR-182-3p, miR -382-3p and miR -93, miR -142-3p involved in tamoxifen resistance and sensitivity in luminal-subtype breast cancer patients: a case–control study},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  volume = {398},
  number = {6},
  pages = {7505--7516},
  doi = {10.1007/s00210-024-03770-9}
}
Kostenlos starten →